TCL Archive Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.” July 18, 2008
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012